Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1979-04-19
1981-01-06
Trousof, Natalie
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
562557, A61K 31195
Patent
active
042436796
ABSTRACT:
S-(3-methyl-2-butenyl)cysteine ##STR1## or a pharmaceutically acceptable salt thereof. The compound is an expectorant and can be applied in the form of capsules or dragees, solutions, syrups or suppositories.
REFERENCES:
patent: 3879560 (1975-04-01), Kalopissis
patent: 3892852 (1975-07-01), Joullie
patent: 3950387 (1976-04-01), Joullie
patent: 3950542 (1976-04-01), Kalopissis
patent: 3984569 (1976-10-01), Kalopissis
Obata, Agr. Biol. Chem., 29, pp. 104-107 (1965).
Adsara Jorge D.
Bruseghini Leonida
Casadio Silvano
Ribalta Jose M. B.
Shippen Michael
Striker Michael J.
Trousof Natalie
LandOfFree
S-(3-Methyl-2-butenyl)cysteine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S-(3-Methyl-2-butenyl)cysteine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S-(3-Methyl-2-butenyl)cysteine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-285189